Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Karen Ireland"'
Autor:
Olivia L. Snir, Megan L. Troxell, Alexis Jaggers, Anya Coleman, Donald C. Houghton, Phoebe M. Hammer, Nicole K. Andeen, Karen Ireland
Publikováno v:
Archives of pathologylaboratory medicine. 146(8)
Context.— The Pathology Medical Student Fellowship (PSF) is a unique, year-long immersive educational experience. Review of institutional archives describes a medical student “Fellowship in Pathology” founded in 1919. Objective.— To character
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40f042f52ab4290a394f7e091543d149
https://pubmed.ncbi.nlm.nih.gov/34784414
https://pubmed.ncbi.nlm.nih.gov/34784414
Autor:
Deepa Manwani, Ellen J. Silver, Makeda Mallea, Suzette O. Oyeku, Ruth E.K. Stein, Jenai Jackson, Maya Doyle, Kerry A Morrone, Karen Ireland, Laurie J. Bauman, Rosy Chhabra, Caterina P. Minniti, Deepa Rastogi, Lynn Davidson
Background Adolescents and young adults (AYA) with Sickle Cell Disease (SCD) experience especially high rates of acute care utilization and increased morbidity, due in part to disease exacerbation and in part to the developmental challenges of adoles
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::64ccdb224b885fc0839f088733c7d385
https://doi.org/10.22541/au.160253847.75056849/v1
https://doi.org/10.22541/au.160253847.75056849/v1
Autor:
Janine Keenan, Deepa Manwani, Paul S. Frenette, George Amatuni, Sung Kyun Lee, Kerry Morrone, Karen Ireland, Jennifer Davila, Hillel W. Cohen, Veronica Carullo, Patricia A. Shi, Chunliang Xu
Publikováno v:
Complementary therapies in medicine. 52
Sickle Cell Disease (SCD) is a chronic hemolytic disorder associated with frequent pain episodes, end organ damage and a shortened lifespan. Currently there exist no disease specific targeted therapies for the treatment of acute vaso-occlusive crisis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84da597fafbb99b93f26fdea9e459806
https://pubmed.ncbi.nlm.nih.gov/32951731
https://pubmed.ncbi.nlm.nih.gov/32951731
Autor:
Arlene Smaldone, Arpan A. Sinha, Karen Ireland, Deepa Manwani, Nancy S. Green, Mahvish Qureshi
Publikováno v:
Pediatric Blood & Cancer. 63:2146-2153
Background Hydroxyurea (HU) induces dose-dependent increased fetal hemoglobin (HbF) for sickle cell disease (SCD). Large deviation from historical personal best (PBest) HbF, a clinic-based version of maximum dose, may identify a subset with suboptima
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ef4d67bbddf0b45481caaa85746ffc4
https://doi.org/10.1002/pbc.26161
https://doi.org/10.1002/pbc.26161
Autor:
Hillel W. Cohen, Lisa Figueiredo, Catherine Wei, Catherine Driscoll, Kerry Morrone, Karen Ireland, Deepa Manwani
Publikováno v:
Blood cells, moleculesdiseases. 66
Hydroxyurea (HU) is a key drug therapy for individuals with sickle cell anemia (SCA), yet its clinical and hematologic responses can be variable. Various studies have reported the role of α-thalassemia as one of the most prevalent heritable traits t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ede9e7d51aec84a5cbd8b325b0d9d97a
https://pubmed.ncbi.nlm.nih.gov/28783617
https://pubmed.ncbi.nlm.nih.gov/28783617
Autor:
Sally E. Findley, Yvonne Stennett, Yina Castillo, Arlene Smaldone, Nancy S. Green, Sergio Matos, April L. Hicks, Luisa Soto, Karen Ireland, Haomiao Jia, Deepa Manwani
Publikováno v:
Pediatric bloodcancer. 64(12)
Introduction The main therapeutic intervention for sickle cell disease (SCD) is hydroxyurea (HU). The effect of HU is largely through dose-dependent induction of fetal hemoglobin (HbF). Poor HU adherence is common among adolescents. Methods Our 6-mon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c667be8c28414fc70c83f7b5567881f
https://pubmed.ncbi.nlm.nih.gov/28643377
https://pubmed.ncbi.nlm.nih.gov/28643377
Autor:
Karen Ireland, Umut A. Gurkan, Jane A. Little, Erina Quinn, Deepa Manwani, Charlotte Yuan, Sargam Kapoor, Janine Keenan
Publikováno v:
Blood. 132:2387-2387
Background: Sickle cell disease (SCD) is characterized by abnormal cellular adhesion to the endothelium, contributing to progressive vasculopathy and vaso-occlusion. The progression of the underlying pathophysiology in SCD with age is not well unders
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::250a2e121614a21edb131aa0bbe6ef70
https://doi.org/10.1182/blood-2018-99-120175
https://doi.org/10.1182/blood-2018-99-120175
Autor:
Jennifer G. Davila, Deepa Manwani, Ljiljana V. Vasovic, Joan Uehlinger, Karen Ireland, Mauro P. Avanzi, W. Beau Mitchell
Publikováno v:
Platelets. 26(8)
The severe pain, ischemia and organ damage that characterizes sickle cell disease (SCD) is caused by vaso-occlusion, which is the blockage of blood vessels by heterotypic aggregates of sickled erythrocytes and other cells. Vaso-occlusion is also a va
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1d7eb5e4a966842513b13c7f036c035
https://pubmed.ncbi.nlm.nih.gov/25548984
https://pubmed.ncbi.nlm.nih.gov/25548984
Autor:
Alfred I. Neugut, Regina M. Santella, Sybil M. Eng, Mary S. Wolff, Marilie D. Gammon, Elena Deych, Susan L. Teitelbaum, Zhisong Liu, Karen Ireland, Julie A. Britton
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 14:2224-2236
Multivariate methods were used to predict levels of dichlorodiphenyldichloroethene (DDE) and polychlorinated biphenyl (PCB) concentrations in plasma from characteristics that included age, diet, race, reproductive history, socioeconomic status, and r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::973f6485f8b7ce922b34d58f594e0ab1
https://doi.org/10.1158/1055-9965.epi-05-0173
https://doi.org/10.1158/1055-9965.epi-05-0173
Autor:
Luisa Torres-Sánchez, Mary S. Wolff, Lizbeth López-Carrillo, Karen Ireland, Jacqueline Moline
Publikováno v:
Environmental Research. 87:131-135
For almost 50 years, millions of Mexicans have been directly and/or indirectly exposed to (1,1,1-trichloro-2,2-bis[p-chlorophenyl]ethane) (p,p'DDT). The potential related health outcomes of this exposure are of international concern. The objective of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86de67402b991b4f7e28f1276ecd0644
https://doi.org/10.1006/enrs.2001.4296
https://doi.org/10.1006/enrs.2001.4296